panitumumab-irdye800
Showing 1 - 7 of 7
Brain Tumor Trial in Stanford (Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera)
Not yet recruiting
- Brain Tumor
- Panitumumab-IRDye800
- +3 more
-
Stanford, CaliforniaStanford Cancer Center
Nov 9, 2022
Pancreatic Adenocarcinoma Trial in Palo Alto (procedure, biological, drug)
Active, not recruiting
- Pancreatic Adenocarcinoma
- Fluorescence Imaging
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Jun 21, 2022
Lung Carcinoma, Metastatic Malignant Tumor in the Lung, Stage IV Lung Cancer AJCC v8 Trial in Palo Alto (procedure, drug, other)
Active, not recruiting
- Lung Carcinoma
- +4 more
- Near-Infrared Fluorescence Imaging
- +3 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Jun 21, 2022
Head Neck Cancer Trial in Birmingham (Panitumumab-IRDye800)
Recruiting
- Head and Neck Cancer
- Panitumumab-IRDye800
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 12, 2021
Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Panitumumab-IRDye800
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jul 13, 2023
Malignant Brain Tumor, Malignant Glioma Trial in Palo Alto (procedure, biological, drug, device)
Suspended
- Malignant Brain Neoplasm
- Malignant Glioma
- Near-Infrared Fluorescence Imaging
- +3 more
-
Palo Alto, CaliforniaStanford University School of Medicine
Aug 10, 2021
Head and Neck Squamous Cell Carcinoma Trial in Palo Alto (Panitumumab-IRDye800, Lymphoseek)
Suspended
- Head and Neck Squamous Cell Carcinoma
- Panitumumab-IRDye800
- Lymphoseek
-
Palo Alto, CaliforniaStanford University, School of Medicine
Aug 16, 2021